Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation (ITATI)

NCT04720742 is registered in ClinicalTrials.gov with IrsiCaixa as lead sponsor.

NCT NCT04720742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04720742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation (ITATI)
Lead sponsor
IrsiCaixa
Phase
Phase 2
Overall status
Withdrawn
Start date
February 28, 2021
Completion date
March 28, 2022
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection